Ozempic emerges as a game-changer in the world of weight loss?

Eli Lilly's Ozempic is gaining traction for its superior efficacy compared to older GLP-1 drugs. The new shot promises significant benefits, sparking intense debate and interest.

Pick a side

Others are taking sides. United States hasn't spoken yet.

France is leading 'Eli Lilly's Ozempic is revolutionizing how we tackle obesity and diabetes due to its unmatched effectiveness over existing treatments.', while Brazil stands for 'Critics argue that Eli Lilly exaggerates Ozempic’s benefits, potentially overlooking potential side effects or downplaying alternatives' efficacy in the hype cycle.'. United States... this is still ours to define.